DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 35 · September 2002 DOI: 10.1055/s-002-2163

Original Paper

159
Seifert, J.; Metzner, C.; Paetzold, W.; Borsutzky, M.; Passie, T.; Rollnik, J.; Wiese, B.; Emrich, H. M.; Schneider, U.: Detoxification of Opiate Addicts with Multiple Drug Abuse: a Comparison of Buprenorphine vs. Methadone
165
Riemann, D.; Voderholzer, U.; Cohrs, S.; Rodenbeck, A.; Hajak, G.; Rüther, E.; Wiegand, M. H.; Laakmann, G.; Baghai, T.; Fischer, W.; Hoffmann, M.; Hohagen, F.; Mayer, G.; Berger, M.: Trimipramine in Primary Insomnia: Results of a Polysomnographic Double-Blind Controlled Study
175
Ueda, N.; Yoshimura, R.; Shinkai, K.; Nakamura, J.: Plasma Levels of Catecholamine Metabolites Predict the Response to Sulpiride or Fluvoxamine in Major Depression
182
Reuter, M.; Siegmund, A.; Netter, P.: The Trigonometric Responder Approach: A New Method for Detecting Responders to Pharmacological or Experimental Challenges
190
Adler, G.; Grieshaber, S.; Faude, V.; Thebaldi, B.; Dressing, H.: Clozapine in Patients with Chronic Schizophrenia: Serum Level, EEG and Memory Performance

Short Communication

195
Samochowiec, J.; Kucharska-Mazur, J.; Rybakowski, F.; Ostapowicz, A.; Horodnicki, J.; Rozpara, M.; Kamiński, R.; Skrzypińska, A.; Arentowicz, G.; Rommelspacher, H.; Schmidt, L.-G.: Norepinephrine Transporter Polymorphism and Personality Trait of Reward Dependence in Male Alcoholics

Case Report

197
Jain, V.; Swartz, C. M.: Charcoal Enhancement of Treatment for Tricyclic-Induced Mania
200
Dietz, A.; Frölich, L.: Mefloquine-induced Paranoid Psychosis and Subsequent Major Depression in a 25-year-old Student